Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Alivus Life Sciences Ltd

NSE: ALIVUS · BSE: 543322 · Pharmaceuticals & Biotechnology · 23 announcements

Share price
₹1,380.00
Market cap
₹16,942 Cr
Revenue (annual)
₹2,552 Cr
Net profit (annual)
₹564.5 Cr
P/E (TTM)
28.1×Sector 47.4×
Promoter holding
74.87%+0.00% QoQ
FII holding
5.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:58 IST BSE
Results Update

Alivus Life Sciences Results Update

Alivus Life Sciences reported Q1 FY27 financial highlights with revenue growing 6.4% YoY to Rs. 6,404 million and PAT rising 31.8% YoY.